{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:06:11Z","timestamp":1789200371061,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020373","name":"Central Council for Research in Homeopathy, Ministry of AYUSH, Government of India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12746-2","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:21:10Z","timestamp":1789197670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular insights and therapeutic innovations in low-risk human papillomavirus-associated cutaneous wart"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1320-8495","authenticated-orcid":false,"given":"Avipsha","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7837-2848","authenticated-orcid":false,"given":"Sayaree","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9353-5777","authenticated-orcid":false,"given":"Tanusree","family":"Ghorai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4772-8333","authenticated-orcid":false,"given":"Debadatta","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9843-3466","authenticated-orcid":false,"given":"Satadal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"12746_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2174\/1389557523666230213140641","volume":"23","author":"W Ahmed","year":"2023","unstructured":"Ahmed W, Zaib S, Ullah S et al (2023) Role of human papillomavirus in various cancers: Epidemiology, screening and prevention. Mini Rev Med Chem 23:1079\u20131089. https:\/\/doi.org\/10.2174\/1389557523666230213140641","journal-title":"Mini Rev Med Chem"},{"key":"12746_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-97-4480-0_25","volume-title":"Emerging Human Viral Diseases","author":"U Kumar","year":"2024","unstructured":"Kumar U, Kumari M, Bhukya PL (2024) Molecular mechanisms of human papillomavirus-induced cervical carcinogenesis. In: Bhukya PL, Subbaiyan A (eds) Emerging Human Viral Diseases, vol II. Springer, Singapore. https:\/\/doi.org\/10.1007\/978-981-97-4480-0_25"},{"issue":"14","key":"12746_CR3","doi-asserted-by":"publisher","first-page":"7616","DOI":"10.3390\/ijms25147616","volume":"25","author":"B Mlynarczyk-Bonikowska","year":"2024","unstructured":"Mlynarczyk-Bonikowska B, Rudnicka L (2024) HPV infections\u2014Classification, Pathogenesis, and Potential New Therapies. Int J Mol Sci 25(14):7616. https:\/\/doi.org\/10.3390\/ijms25147616","journal-title":"Int J Mol Sci"},{"key":"12746_CR4","doi-asserted-by":"publisher","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","volume":"30","author":"J Doorbar","year":"2012","unstructured":"Doorbar J, Quint W, Banks L et al (2012) The biology and life-cycle of human papillomaviruses. Vaccine 30:F55\u2013F70. https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.083","journal-title":"Vaccine"},{"key":"12746_CR5","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","volume":"30","author":"D Forman","year":"2012","unstructured":"Forman D, de Martel C, Lacey CJ et al (2012) Global burden of human papillomavirus and related diseases. Vaccine 30:F12\u2013F23. https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.055","journal-title":"Vaccine"},{"key":"12746_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/CMR.00013-15","volume":"29","author":"EM Burd","year":"2016","unstructured":"Burd EM (2016) Human papillomavirus laboratory testing: The changing paradigm. Clin Microbiol Rev 29:291\u2013319. https:\/\/doi.org\/10.1128\/CMR.00013-15","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"12746_CR7","doi-asserted-by":"publisher","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","volume":"17","author":"KA Szymonowicz","year":"2020","unstructured":"Szymonowicz KA, Chen J (2020) Biological and clinical aspects of HPV-related cancers. Cancer Biol Med 17(4):864\u2013878. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0370","journal-title":"Cancer Biol Med"},{"key":"12746_CR8","doi-asserted-by":"publisher","unstructured":"Lacey CJN, Guimer\u00e0 N, Garland SM (2020) Low-risk human papillomavirus: Genital warts, cancer and respiratory papillomatosis. Acad Press 165\u2013178. https:\/\/doi.org\/10.1016\/B978-0-12-814457-2.00010-6","DOI":"10.1016\/B978-0-12-814457-2.00010-6"},{"key":"12746_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.virusres.2016.12.017","volume":"231","author":"N Egawa","year":"2017","unstructured":"Egawa N, Doorbar J (2017) The low-risk papillomaviruses. Virus Res 231:119\u2013127. https:\/\/doi.org\/10.1016\/j.virusres.2016.12.017","journal-title":"Virus Res"},{"key":"12746_CR10","unstructured":"Centers for Disease Control and Prevention (CDC) (2024) Human Papillomavirus (HPV). https:\/\/www.cdc.gov\/hpv\/index.html. Accessed 1 July 2026"},{"key":"12746_CR11","doi-asserted-by":"publisher","first-page":"104736","DOI":"10.1016\/j.oraloncology.2020.104736","volume":"108","author":"AR Kreimer","year":"2020","unstructured":"Kreimer AR, Chaturvedi AK, Alemany L et al (2020) Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. Oral Oncol 108:104736. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104736","journal-title":"Oral Oncol"},{"key":"12746_CR12","unstructured":"World Health Organisation (WHO) 2023 Fact Sheet Human Papillomavirus (HPV). https:\/\/www.who.int\/news-room\/fact-sheets"},{"key":"12746_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2334-13-39","volume":"13","author":"H Patel","year":"2013","unstructured":"Patel H, Wagner M, Singhal P, Kothari S (2013) Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis 13:39. https:\/\/doi.org\/10.1186\/1471-2334-13-39","journal-title":"BMC Infect Dis"},{"key":"12746_CR14","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.str.2024.09.011","volume":"32","author":"F Han","year":"2024","unstructured":"Han F, Guo XY, Jiang MX et al (2024) Structural biology of the human papillomavirus. Structure 32:1877\u20131892. https:\/\/doi.org\/10.1016\/j.str.2024.09.011","journal-title":"Structure"},{"issue":"8","key":"12746_CR15","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1515\/hsz-2017-0113","volume":"398","author":"AA McBride","year":"2017","unstructured":"McBride AA (2017) Mechanisms and strategies of papillomavirus replication. Biol Chem 398(8):919\u2013927. https:\/\/doi.org\/10.1515\/hsz-2017-0113","journal-title":"Biol Chem"},{"key":"12746_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41392-024-02083-w","volume":"10","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Qiu K, Ren J et al (2025) Roles of human papillomavirus in cancers: Oncogenic mechanisms and clinical use. Signal Transduct Target Ther 10:44. https:\/\/doi.org\/10.1038\/s41392-024-02083-w","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"12746_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu FX, Zhao B, Guan KL (2015) Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163(4):811\u2013828. https:\/\/doi.org\/10.1016\/j.cell.2015.10.044","journal-title":"Cell"},{"key":"12746_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12920-020-0700-7","volume":"13","author":"LN Al-Eitan","year":"2020","unstructured":"Al-Eitan LN, Tarkhan AH, Alghamdi MA et al (2020) Transcriptome analysis of HPV-induced warts and healthy skin in humans. BMC Med Genomics 13:35. https:\/\/doi.org\/10.1186\/s12920-020-0700-7","journal-title":"BMC Med Genomics"},{"issue":"18","key":"12746_CR19","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.3390\/cancers14194623","volume":"14","author":"VL Porter","year":"2022","unstructured":"Porter VL, Marra MA (2022) The drivers, mechanisms, and consequences of genome instability in HPV-driven cancers. Cancers 14(18):4623. https:\/\/doi.org\/10.3390\/cancers14194623","journal-title":"Cancers"},{"key":"12746_CR20","doi-asserted-by":"publisher","first-page":"e539s","DOI":"10.6061\/clinics\/2018\/e539s","volume":"73","author":"B Prati","year":"2018","unstructured":"Prati B, Marangoni B, Boccardo E (2018) Human papillomavirus and genome instability: From productive infection to cancer. Clinics 73:e539s. https:\/\/doi.org\/10.6061\/clinics\/2018\/e539s","journal-title":"Clinics"},{"issue":"9","key":"12746_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/v9090261","volume":"9","author":"CA Moody","year":"2017","unstructured":"Moody CA (2017) Mechanisms by which HPV induces a replication-competent environment in differentiating keratinocytes. Viruses 9(9):261. https:\/\/doi.org\/10.3390\/v9090261","journal-title":"Viruses"},{"key":"12746_CR22","doi-asserted-by":"publisher","first-page":"200268","DOI":"10.1016\/j.tvr.2023.200268","volume":"16","author":"J Doorbar","year":"2023","unstructured":"Doorbar J (2023) The human papillomavirus twilight zone \u2013 Latency, immune control and subclinical infection. Tumour Virus Res 16:200268. https:\/\/doi.org\/10.1016\/j.tvr.2023.200268","journal-title":"Tumour Virus Res"},{"key":"12746_CR23","doi-asserted-by":"publisher","first-page":"a012997","DOI":"10.1101\/cshperspect.a012997","volume":"5","author":"LT Chow","year":"2013","unstructured":"Chow LT, Broker TR (2013) Human papillomavirus infections: Warts or cancer? Cold Spring Harb Perspect Biol 5:a012997. https:\/\/doi.org\/10.1101\/cshperspect.a012997","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"12746_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clindermatol.2025.09.012","volume":"43","author":"M Kohli","year":"2025","unstructured":"Kohli M, Bunker CB, Kravvas G (2025) Human papillomavirus: An update. Clin Dermatol 43(1):1\u201312. https:\/\/doi.org\/10.1016\/j.clindermatol.2025.09.012","journal-title":"Clin Dermatol"},{"issue":"3","key":"12746_CR25","doi-asserted-by":"publisher","first-page":"e0339693","DOI":"10.1371\/journal.pone.0339693","volume":"21","author":"MA Ayass","year":"2026","unstructured":"Ayass MA, Zaman N, Griko N et al (2026) Non-invasive host transcriptome and HPV oncogene expression map the molecular landscape of HPV-driven cervical lesions. PLoS ONE 21(3):e0339693. https:\/\/doi.org\/10.1371\/journal.pone.0339693","journal-title":"PLoS ONE"},{"key":"12746_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12985-025-02903-7","volume":"22","author":"S Fletcher","year":"2025","unstructured":"Fletcher S, Biswas-Fiss EE, Biswas SB (2025) Structural and functional roles of conserved residues of human papillomavirus (HPV) E2 protein and biological consequences. Virol J 22:36. https:\/\/doi.org\/10.1186\/s12985-025-02903-7","journal-title":"Virol J"},{"issue":"5","key":"12746_CR27","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade KS (2020) Human papillomavirus and cervical cancer. J Obstet Gynaecol 40(5):602\u2013608. https:\/\/doi.org\/10.1080\/01443615.2019.1634030","journal-title":"J Obstet Gynaecol"},{"issue":"11","key":"12746_CR28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41579-018-0064-6","volume":"16","author":"NA Krump","year":"2018","unstructured":"Krump NA, You J (2018) Molecular mechanisms of viral oncogenesis in humans. Nat Rev Microbiol 16(11):684\u2013698. https:\/\/doi.org\/10.1038\/s41579-018-0064-6","journal-title":"Nat Rev Microbiol"},{"key":"12746_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41392-025-02197-9","volume":"10","author":"Q Xiao","year":"2025","unstructured":"Xiao Q, Liu Y, Li T et al (2025) Viral oncogenesis in cancer: from mechanisms to therapeutics. Sig Transduct Target Ther 10:151. https:\/\/doi.org\/10.1038\/s41392-025-02197-9","journal-title":"Sig Transduct Target Ther"},{"key":"12746_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.semradonc.2021.02.006","volume":"31","author":"PF Cosper","year":"2021","unstructured":"Cosper PF, Bradley S, Luo L, Kimple RJ (2021) Biology of HPV mediated carcinogenesis and tumor progression. Semin Radiat Oncol 31:265\u2013273. https:\/\/doi.org\/10.1016\/j.semradonc.2021.02.006","journal-title":"Semin Radiat Oncol"},{"issue":"4","key":"12746_CR31","doi-asserted-by":"publisher","first-page":"e1006211","DOI":"10.1371\/journal.ppat.1006211","volume":"13","author":"AA McBride","year":"2017","unstructured":"McBride AA, Warburton A (2017) The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog 13(4):e1006211. https:\/\/doi.org\/10.1371\/journal.ppat.1006211","journal-title":"PLoS Pathog"},{"issue":"9","key":"12746_CR32","doi-asserted-by":"publisher","first-page":"e24451","DOI":"10.1371\/journal.pone.0024451","volume":"6","author":"S Vinokurova","year":"2011","unstructured":"Vinokurova S, von Knebel Doeberitz M (2011) Differential methylation of the HPV16 upstream regulatory region during epithelial differentiation and neoplastic transformation. PLoS ONE 6(9):e24451. https:\/\/doi.org\/10.1371\/journal.pone.0024451","journal-title":"PLoS ONE"},{"key":"12746_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41419-025-08195-7","volume":"17","author":"L Wang","year":"2026","unstructured":"Wang L, Li X, Ren C et al (2026) Site-specific HPV18 integration facilitates cervical carcinogenesis through metabolic reprogramming-induced dysfunction of the SpHK1\/S1P\/S1PR1 pathway. Cell Death Dis 17:24. https:\/\/doi.org\/10.1038\/s41419-025-08195-7","journal-title":"Cell Death Dis"},{"issue":"2","key":"12746_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.virol.2008.11.014","volume":"384","author":"F Thierry","year":"2009","unstructured":"Thierry F (2009) Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 384(2):375\u2013379. https:\/\/doi.org\/10.1016\/j.virol.2008.11.014","journal-title":"Virology"},{"issue":"9","key":"12746_CR35","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3390\/v15112253","volume":"15","author":"J Skelin","year":"2023","unstructured":"Skelin J, Tomai\u0107 V (2023) Comparative analysis of alpha and beta HPV E6 oncoproteins: Insights into functional distinctions and divergent mechanisms of pathogenesis. Viruses 15(9):1898. https:\/\/doi.org\/10.3390\/v15112253","journal-title":"Viruses"},{"key":"12746_CR36","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3389\/fmicb.2019.03116","volume":"10","author":"A Pal","year":"2020","unstructured":"Pal A, Kundu R (2020) Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Front Microbiol 10:3116. https:\/\/doi.org\/10.3389\/fmicb.2019.03116","journal-title":"Front Microbiol"},{"key":"12746_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-virology-100114-055021","volume":"2","author":"NA Wallace","year":"2015","unstructured":"Wallace NA, Galloway DA (2015) Novel functions of the human papillomavirus E6 oncoproteins. Annu Rev Virol 2:403\u2013423. https:\/\/doi.org\/10.1146\/annurev-virology-100114-055021","journal-title":"Annu Rev Virol"},{"issue":"9590","key":"12746_CR38","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370(9590):890\u2013907. https:\/\/doi.org\/10.1016\/S0140-6736(07)61416-0","journal-title":"Lancet"},{"issue":"2","key":"12746_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1128\/CMR.05028-11","volume":"25","author":"MA Stanley","year":"2012","unstructured":"Stanley MA (2012) Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev 25(2):215\u2013222. https:\/\/doi.org\/10.1128\/CMR.05028-11","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"12746_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tim.2017.07.007","volume":"26","author":"K Hoppe-Seyler","year":"2018","unstructured":"Hoppe-Seyler K, Bossler F, Braun JA et al (2018) The HPV E6\/E7 oncogenes: Key factors for viral carcinogenesis and therapeutic targets. Trends Microbiol 26(2):158\u2013168. https:\/\/doi.org\/10.1016\/j.tim.2017.07.007","journal-title":"Trends Microbiol"},{"key":"12746_CR41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1874357901206010249","volume":"6","author":"AK Grabowska","year":"2012","unstructured":"Grabowska AK, Riemer AB (2012) The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J 6:249\u2013256. https:\/\/doi.org\/10.2174\/1874357901206010249","journal-title":"Open Virol J"},{"key":"12746_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.virusres.2016.11.023","volume":"231","author":"JA Westrich","year":"2017","unstructured":"Westrich JA, Warren CJ, Pyeon D (2017) Evasion of host immune defenses by human papillomavirus. Virus Res 231:21\u201333. https:\/\/doi.org\/10.1016\/j.virusres.2016.11.023","journal-title":"Virus Res"},{"key":"12746_CR43","doi-asserted-by":"publisher","first-page":"e28310","DOI":"10.1002\/jmv.28310","volume":"95","author":"M Lou","year":"2022","unstructured":"Lou M, Huang D, Zhou Z et al (2022) DNA virus oncoprotein HPV18 E7 selectively antagonizes cGAS-STING-triggered innate immune activation. J Med Virol 95:e28310. https:\/\/doi.org\/10.1002\/jmv.28310","journal-title":"J Med Virol"},{"key":"12746_CR44","doi-asserted-by":"publisher","first-page":"e01925","DOI":"10.1128\/jvi.01925-23","volume":"98","author":"L Chen","year":"2024","unstructured":"Chen L, Hu H, Pan Y et al (2024) The role of HPV11 E7 in modulating STING-dependent interferon \u03b2 response in recurrent respiratory papillomatosis. J Virol 98:e01925\u2013e01923. https:\/\/doi.org\/10.1128\/jvi.01925-23","journal-title":"J Virol"},{"issue":"17","key":"12746_CR45","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1042\/CS20160786","volume":"131","author":"SV Graham","year":"2017","unstructured":"Graham SV (2017) The human papillomavirus replication cycle, and its links to cancer progression: A comprehensive review. Clin Sci (Lond) 131(17):2201\u20132221. https:\/\/doi.org\/10.1042\/CS20160786","journal-title":"Clin Sci (Lond)"},{"key":"12746_CR46","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2217\/fmb.09.86","volume":"4","author":"PM Day","year":"2009","unstructured":"Day PM, Schiller JT (2009) The role of furin in papillomavirus infection. Future Microbiol 4:1255\u20131262. https:\/\/doi.org\/10.2217\/fmb.09.86","journal-title":"Future Microbiol"},{"key":"12746_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000355952","volume":"45","author":"A Harari","year":"2014","unstructured":"Harari A, Chen Z, Burk RD (2014) Human papillomavirus genomics: Past, present and future. Curr Probl Dermatol 45:1\u201318. https:\/\/doi.org\/10.1159\/000355952","journal-title":"Curr Probl Dermatol"},{"key":"12746_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mrrev.2016.09.004","volume":"772","author":"P Aksoy","year":"2017","unstructured":"Aksoy P, Gottschalk EY, Meneses PI (2017) HPV entry into cells. Mutat Research\/Reviews Mutat Res 772:13\u201322. https:\/\/doi.org\/10.1016\/j.mrrev.2016.09.004","journal-title":"Mutat Research\/Reviews Mutat Res"},{"key":"12746_CR49","doi-asserted-by":"publisher","unstructured":"Doorbar J, Egawa N, Griffin H et al (2015) Human papillomavirus molecular biology and disease association. Rev Med Virol 2\u201323. https:\/\/doi.org\/10.1002\/rmv.1822","DOI":"10.1002\/rmv.1822"},{"issue":"4","key":"12746_CR50","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.coviro.2013.06.003","volume":"3","author":"J Doorbar","year":"2013","unstructured":"Doorbar J (2013) Latent papillomavirus infections and their regulation. Curr Opin Virol 3(4):416\u2013421. https:\/\/doi.org\/10.1016\/j.coviro.2013.06.003","journal-title":"Curr Opin Virol"},{"issue":"6","key":"12746_CR51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.smim.2006.07.008","volume":"18","author":"G Orth","year":"2006","unstructured":"Orth G (2006) Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin Immunol 18(6):362\u2013374. https:\/\/doi.org\/10.1016\/j.smim.2006.07.008","journal-title":"Semin Immunol"},{"issue":"11","key":"12746_CR52","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1128\/JVI.00330-13","volume":"87","author":"AB Raff","year":"2013","unstructured":"Raff AB, Woodham AW, Raff LM et al (2013) The evolving field of human papillomavirus receptor research: A review of binding and entry. J Virol 87(11):6062\u20136072. https:\/\/doi.org\/10.1128\/JVI.00330-13","journal-title":"J Virol"},{"issue":"2","key":"12746_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1101\/gad.1735109","volume":"23","author":"HK Wang","year":"2009","unstructured":"Wang HK, Duffy AA, Broker TR, Chow LT (2009) Robust production and passaging of infectious human papillomavirus in squamous epithelium of primary human keratinocytes. Genes Dev 23(2):181\u2013194. https:\/\/doi.org\/10.1101\/gad.1735109","journal-title":"Genes Dev"},{"issue":"12","key":"12746_CR54","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.3390\/cancers12123772","volume":"12","author":"ML Tornesello","year":"2020","unstructured":"Tornesello ML, Buonaguro FM (2020) Human papillomavirus and cancers. Cancers 12(12):3772. https:\/\/doi.org\/10.3390\/cancers12123772","journal-title":"Cancers"},{"issue":"48","key":"12746_CR55","doi-asserted-by":"publisher","first-page":"20458","DOI":"10.1073\/pnas.0908502106","volume":"106","author":"RC Kines","year":"2009","unstructured":"Kines RC, Thompson CD, Lowy DR, Schiller JT (2009) The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci USA 106(48):20458\u201320463. https:\/\/doi.org\/10.1073\/pnas.0908502106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"12746_CR56","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1128\/JVI.75.3.1565-1570.2001","volume":"75","author":"T Giroglou","year":"2001","unstructured":"Giroglou T, Florin L, Sch\u00e4fer F et al (2001) Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75(3):1565\u20131570. https:\/\/doi.org\/10.1128\/JVI.75.3.1565-1570.2001","journal-title":"J Virol"},{"issue":"7","key":"12746_CR57","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1128\/JVI.03222-12","volume":"87","author":"PM Day","year":"2013","unstructured":"Day PM, Thompson CD, Schowalter RM et al (2013) Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. J Virol 87(7):3862\u20133870. https:\/\/doi.org\/10.1128\/JVI.03222-12","journal-title":"J Virol"},{"key":"12746_CR58","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2886","volume":"10","author":"C Moody","year":"2010","unstructured":"Moody C, Laimins L (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10:550\u2013560. https:\/\/doi.org\/10.1038\/nrc2886","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"12746_CR59","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1128\/jvi.00751-11","volume":"86","author":"T Mespl\u00e8de","year":"2012","unstructured":"Mespl\u00e8de T, Gagnon D, Bergeron-Labrecque F et al (2012) p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes. J Virol 86(1):94\u2013107. https:\/\/doi.org\/10.1128\/jvi.00751-11","journal-title":"J Virol"},{"key":"12746_CR60","doi-asserted-by":"publisher","first-page":"7888","DOI":"10.1038\/sj.onc.1204860","volume":"20","author":"K Munger","year":"2001","unstructured":"Munger K, Duensing S, Eichten A et al (2001) Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888\u20137898. https:\/\/doi.org\/10.1038\/sj.onc.1204860","journal-title":"Oncogene"},{"key":"12746_CR61","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1476-4598-10-140","volume":"10","author":"A Venuti","year":"2011","unstructured":"Venuti A, Paolini F, Nasir L et al (2011) Papillomavirus E5: The smallest oncoprotein with many functions. Mol Cancer 10:140. https:\/\/doi.org\/10.1186\/1476-4598-10-140","journal-title":"Mol Cancer"},{"key":"12746_CR62","doi-asserted-by":"publisher","unstructured":"Banerjee NS, Genovese NJ, Noya F et al (2006) Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes. J Virol 80. https:\/\/doi.org\/10.1128\/jvi.02499-05","DOI":"10.1128\/jvi.02499-05"},{"key":"12746_CR63","doi-asserted-by":"publisher","unstructured":"Genovese NJ, Banerjee NS, Broker TR, Chow LT (2008) casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes. J Virol 82. https:\/\/doi.org\/10.1128\/jvi.01202-07","DOI":"10.1128\/jvi.01202-07"},{"key":"12746_CR64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12943-015-0361-x","volume":"14","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wu J, Ling MT et al (2015) The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by human papillomaviruses. Mol Cancer 14:87. https:\/\/doi.org\/10.1186\/s12943-015-0361-x","journal-title":"Mol Cancer"},{"issue":"2","key":"12746_CR65","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1128\/JVI.78.2.821-833.2004","volume":"78","author":"Q Wang","year":"2004","unstructured":"Wang Q, Griffin H, Southern S et al (2004) Functional analysis of the human papillomavirus type 16 E1^E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J Virol 78(2):821\u2013833. https:\/\/doi.org\/10.1128\/JVI.78.2.821-833.2004","journal-title":"J Virol"},{"issue":"2","key":"12746_CR66","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/j.jgeb.2025.100485","volume":"23","author":"N Kashani","year":"2025","unstructured":"Kashani N, Sabbaghian A, Ahmadi K et al (2025) In silico drug repurposing for potential HPV-induced skin wart treatment \u2013 A comparative transcriptome analysis. J Genet Eng Biotechnol 23(2):100485. https:\/\/doi.org\/10.1016\/j.jgeb.2025.100485","journal-title":"J Genet Eng Biotechnol"},{"issue":"3","key":"12746_CR67","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A (2017) AKT\/PKB signaling: Navigating the network. Cell 169(3):381\u2013405. https:\/\/doi.org\/10.1016\/j.cell.2017.04.001","journal-title":"Cell"},{"issue":"10","key":"12746_CR68","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1242\/dev.133728","volume":"143","author":"A Elbediwy","year":"2016","unstructured":"Elbediwy A, Vincent-Mistiaen ZI, Spencer-Dene B et al (2016) Integrin signalling regulates YAP and TAZ to control skin homeostasis. Development 143(10):1674\u20131687. https:\/\/doi.org\/10.1242\/dev.133728","journal-title":"Development"},{"issue":"5","key":"12746_CR69","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/cells8050411","volume":"8","author":"E Rognoni","year":"2019","unstructured":"Rognoni E, Walko G (2019) The Roles of YAP\/TAZ and the Hippo Pathway in Healthy and Diseased Skin. Cells 8(5):411. https:\/\/doi.org\/10.3390\/cells8050411","journal-title":"Cells"},{"issue":"2","key":"12746_CR70","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/path.4656","volume":"238","author":"J Doorbar","year":"2016","unstructured":"Doorbar J (2016) Model systems of human papillomavirus-associated disease. J Pathol 238(2):166\u2013179. https:\/\/doi.org\/10.1002\/path.4656","journal-title":"J Pathol"},{"issue":"3","key":"12746_CR71","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/jebm.12494","volume":"15","author":"P Zhu","year":"2022","unstructured":"Zhu P, Qi RQ, Yang Y et al (2022) Clinical guideline for the diagnosis and treatment of cutaneous warts. J Evid Based Med 15(3):284\u2013301. https:\/\/doi.org\/10.1111\/jebm.12494","journal-title":"J Evid Based Med"},{"issue":"6","key":"12746_CR72","doi-asserted-by":"publisher","first-page":"e15480","DOI":"10.1111\/dth.15480","volume":"35","author":"S Garc\u00eda-Oreja","year":"2022","unstructured":"Garc\u00eda-Oreja S, \u00c1lvaro-Afonso FJ, Tard\u00e1guila-Garc\u00eda A et al (2022) Efficacy of cryotherapy for plantar warts: A systematic review and meta-analysis. Dermatol Ther 35(6):e15480. https:\/\/doi.org\/10.1111\/dth.15480","journal-title":"Dermatol Ther"},{"issue":"4","key":"12746_CR73","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3121\/cmr.4.4.273","volume":"4","author":"MM Lipke","year":"2006","unstructured":"Lipke MM (2006) An armamentarium of wart treatments. Clin Med Res 4(4):273\u2013293. https:\/\/doi.org\/10.3121\/cmr.4.4.273","journal-title":"Clin Med Res"},{"key":"12746_CR74","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jocd.13593","volume":"20","author":"A Zorman","year":"2021","unstructured":"Zorman A, Koron N (2021) Wart removal without anesthesia using long-pulse 1064-nm Nd:YAG laser. J Cosmet Dermatol 20:506\u2013512. https:\/\/doi.org\/10.1111\/jocd.13593","journal-title":"J Cosmet Dermatol"},{"key":"12746_CR75","doi-asserted-by":"publisher","first-page":"104407","DOI":"10.1016\/j.pdpdt.2024.104407","volume":"51","author":"J Chen","year":"2025","unstructured":"Chen J, Xie X, Liu Y et al (2025) Application of photodynamic therapy with 5-aminolevulinic acid and fractional CO2 laser for the management of recalcitrant plantar warts. Photodiagnosis Photodyn Ther 51:104407. https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104407","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"11","key":"12746_CR76","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3390\/vaccines9111280","volume":"9","author":"NM Hammad","year":"2021","unstructured":"Hammad NM, Marei A, El-Didamony G et al (2021) Predictors of the therapeutic response to intralesional bivalent HPV vaccine in wart immunotherapy. Vaccines (Basel) 9(11):1323. https:\/\/doi.org\/10.3390\/vaccines9111280","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"12746_CR77","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/bjd.13310","volume":"171","author":"JC Sterling","year":"2014","unstructured":"Sterling JC, Gibbs S, Haque Hussain SS et al (2014) British Association of Dermatologists\u2019 guidelines for the management of cutaneous warts. Br J Dermatol 171(4):696\u2013712. https:\/\/doi.org\/10.1111\/bjd.13310","journal-title":"Br J Dermatol"},{"key":"12746_CR78","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.intimp.2019.02.026","volume":"70","author":"A Jafarzadeh","year":"2019","unstructured":"Jafarzadeh A, Nemati M, Khorramdelazad H, Hassan ZM (2019) Immunomodulatory properties of cimetidine: Its therapeutic potentials for treatment of immune-related diseases. Int Immunopharmacol 70:156\u2013166. https:\/\/doi.org\/10.1016\/j.intimp.2019.02.026","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"12746_CR79","doi-asserted-by":"publisher","first-page":"745","DOI":"10.20471\/acc.2020.59.04.22","volume":"59","author":"I Mur\u0161i\u0107","year":"2020","unstructured":"Mur\u0161i\u0107 I, V\u010dev A, Kotrulja L et al (2020) Treatment of verruca vulgaris in traditional medicine. Acta Clin Croat 59(4):745\u2013750. https:\/\/doi.org\/10.20471\/acc.2020.59.04.22","journal-title":"Acta Clin Croat"},{"issue":"1","key":"12746_CR80","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/0974-8520.85739","volume":"32","author":"URS Namburi","year":"2011","unstructured":"Namburi URS, Omprakash, Babu G (2011) A review on management of warts in Ayurveda. Ayu 32(1):100. https:\/\/doi.org\/10.4103\/0974-8520.85739","journal-title":"Ayu"},{"issue":"3","key":"12746_CR81","doi-asserted-by":"publisher","first-page":"444","DOI":"10.33545\/26164485.2025.v9.i3.G.1692","volume":"9","author":"AO Vigneshwari","year":"2025","unstructured":"Vigneshwari AO, Vindhya Vikasini C, Vigneshwara Sowjanya S, Sibin RA (2025) A comprehensive review of the efficacy of homoeopathic remedies in the management of wart. Int J Hom Sci 9(3):444\u2013447. https:\/\/doi.org\/10.33545\/26164485.2025.v9.i3.G.1692","journal-title":"Int J Hom Sci"},{"issue":"3","key":"12746_CR82","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/ijms26030939","volume":"26","author":"K Younes","year":"2025","unstructured":"Younes K, Abouzied A, Alqarni S, Elkashlan A et al (2025) Biological Activities and Phytochemical Screening of Thuja occidentalis Extracts with In Silico Approaches. Int J Mol Sci 26(3):939. https:\/\/doi.org\/10.3390\/ijms26030939","journal-title":"Int J Mol Sci"},{"issue":"5","key":"12746_CR83","doi-asserted-by":"publisher","first-page":"362","DOI":"10.4103\/0971-4065.116316","volume":"23","author":"R Joseph","year":"2013","unstructured":"Joseph R, Pulimood SA, Abraham P et al (2013) Successful treatment of verruca vulgaris with Thuja occidentalis in a renal allograft recipient. Indian J Nephrol 23(5):362\u2013364. https:\/\/doi.org\/10.4103\/0971-4065.116316","journal-title":"Indian J Nephrol"},{"issue":"3","key":"12746_CR84","doi-asserted-by":"publisher","first-page":"222","DOI":"10.33545\/26164485.2025.v9.i3.D.1655","volume":"9","author":"A GA","year":"2025","unstructured":"GA A, MS RA A et al (2025) Retrospective study on comparative effectiveness of various homoeopathic potencies in treating dermatitis. Int J Homoeopathic Sci 9(3):222\u2013225. https:\/\/doi.org\/10.33545\/26164485.2025.v9.i3.D.1655","journal-title":"Int J Homoeopathic Sci"},{"key":"12746_CR85","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1055\/s-0040-1722232","volume":"110","author":"S Dey","year":"2021","unstructured":"Dey S, Hashmi S, Saha S et al (2021) A Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Individualized Homeopathic Medicines for Cutaneous Warts. Homeopathy 110:149\u2013159. https:\/\/doi.org\/10.1055\/s-0040-1722232","journal-title":"Homeopathy"},{"issue":"4","key":"12746_CR86","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4103\/ijdvl.IJDVL_519_17","volume":"85","author":"MI Singh","year":"2019","unstructured":"Singh MI, Mahajan VK, Chauhan PS et al (2019) Evaluation of efficacy and safety of intralesional bleomycin in the treatment of common warts: Results of a pilot study. Indian J Dermatol Venereol Leprol 85(4):397\u2013404. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_519_17","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"12746_CR87","doi-asserted-by":"publisher","first-page":"102913","DOI":"10.1016\/j.pdpdt.2022.102913","volume":"39","author":"S Shen","year":"2022","unstructured":"Shen S, Feng J, Song X, Xiang W (2022) Efficacy of photodynamic therapy for warts induced by human papilloma virus infection: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther 39:102913. https:\/\/doi.org\/10.1016\/j.pdpdt.2022.102913","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"7","key":"12746_CR88","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1586\/14760584.2016.1157479","volume":"15","author":"RT Jiang","year":"2016","unstructured":"Jiang RT, Schellenbacher C, Chackerian B et al (2016) Progress and prospects for L2-based human papillomavirus vaccines. Expert Rev Vaccines 15(7):853\u2013862. https:\/\/doi.org\/10.1586\/14760584.2016.1157479","journal-title":"Expert Rev Vaccines"},{"key":"12746_CR89","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jdrv.2025.06.004","volume":"6","author":"MO Michael","year":"2025","unstructured":"Michael MO, Rachel CB, Elmar AJ et al (2025) Human papillomavirus vaccine for the prevention and treatment of warts: A clinical review. JAAD Reviews 6:12\u201322. https:\/\/doi.org\/10.1016\/j.jdrv.2025.06.004","journal-title":"JAAD Reviews"},{"key":"12746_CR90","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/09546630310016763","volume":"14","author":"G Micali","year":"2004","unstructured":"Micali G, Dall\u2019Oglio F, Nasca MR (2004) An open label evaluation of the efficacy of imiquimod 5% cream in the treatment of recalcitrant subungual and periungual cutaneous warts. J Dermatolog Treat 14:233\u2013236. https:\/\/doi.org\/10.1080\/09546630310016763","journal-title":"J Dermatolog Treat"},{"issue":"12","key":"12746_CR91","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.3390\/ijms26125644","volume":"26","author":"E Kucharczyk","year":"2025","unstructured":"Kucharczyk E, Paw\u0142uszkiewicz K, Bili\u0144ski K et al (2025) Intralesional immunotherapy for non-genital viral warts: A review of current evidence and future perspectives. Int J Mol Sci 26(12):5644. https:\/\/doi.org\/10.3390\/ijms26125644","journal-title":"Int J Mol Sci"},{"key":"12746_CR92","doi-asserted-by":"publisher","first-page":"103934","DOI":"10.1016\/j.pdpdt.2023.103934","volume":"45","author":"W Zhang","year":"2024","unstructured":"Zhang W, Jin Z, Gao T et al (2024) Topical 5-aminolevulinic acid photodynamic therapy for recalcitrant facial flat warts. Photodiagnosis Photodyn Ther 45:103934. https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103934","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"4","key":"12746_CR93","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4103\/ijd.ijd_805_24","volume":"70","author":"A Ghosh","year":"2025","unstructured":"Ghosh A, Chatterjee S, Dawn A et al (2025) HPV vaccines \u2013 An overview. Indian J Dermatol 70(4):188\u2013200. https:\/\/doi.org\/10.4103\/ijd.ijd_805_24","journal-title":"Indian J Dermatol"},{"issue":"1","key":"12746_CR94","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/0009922817691536","volume":"57","author":"M Haque","year":"2018","unstructured":"Haque M, Coury DL (2018) Topical sandalwood oil for common warts. Clin Pediatr (Phila) 57(1):93\u201395. https:\/\/doi.org\/10.1177\/0009922817691536","journal-title":"Clin Pediatr (Phila)"},{"key":"12746_CR95","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pvr.2019.03.006","volume":"7","author":"S Smola","year":"2019","unstructured":"Smola S (2019) Immune deviation and cervical carcinogenesis. Papillomavirus Res 7:164\u2013167. https:\/\/doi.org\/10.1016\/j.pvr.2019.03.006","journal-title":"Papillomavirus Res"},{"key":"12746_CR96","doi-asserted-by":"publisher","first-page":"103675","DOI":"10.1016\/j.critrevonc.2022.103675","volume":"174","author":"R Bhattacharjee","year":"2022","unstructured":"Bhattacharjee R, Das SS, Biswal SS et al (2022) Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies. Crit Rev Oncol Hematol 174:103675. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103675","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"12746_CR97","doi-asserted-by":"publisher","first-page":"e1003384","DOI":"10.1371\/journal.ppat.1003384","volume":"9","author":"R Karim","year":"2013","unstructured":"Karim R, Tummers B, Meyers C et al (2013) Human Papillomavirus (HPV) Upregulates the Cellular Deubiquitinase UCHL1 to Suppress the Keratinocyte\u2019s Innate Immune Response. PLoS Pathog 9(5):e1003384. https:\/\/doi.org\/10.1371\/journal.ppat.1003384","journal-title":"PLoS Pathog"},{"issue":"10","key":"12746_CR98","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrmicro2872","volume":"10","author":"JT Schiller","year":"2012","unstructured":"Schiller JT, Lowy DR (2012) Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol 10(10):681\u2013692. https:\/\/doi.org\/10.1038\/nrmicro2872","journal-title":"Nat Rev Microbiol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12746-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12746-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12746-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:21:13Z","timestamp":1789197673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12746-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12746"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12746-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"24 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1565"}}